• About Us
    • Contact Us
    • Login
    • ObGFirst
  • COVID-19
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • #GrandRounds
  • My Bookshelf
  • Now@ObG
  • Media
About Us Contact Us Login ObGFirst
  • COVID-19
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • 0 CME Hours
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • #GrandRounds
  • My Bookshelf
  • Now@ObG
  • Media
#Grand Rounds

Does a Mediterranean Diet with Extra Olive Oil Decrease Risk of Gestational Diabetes Mellitus?

image_pdfFavoriteLoadingFavorite

BACKGROUND AND PURPOSE:

  • Thus far, effective lifestyle prevention measures to prevent gestational diabetes mellitus (GDM) have been limited
  • A Mediterranean Diet (MedDiet), with additional extra virgin olive oil (EVOO) and nuts, prevents type 2 DM and cardiovascular disease
  • Retrospective data indicate that MedDiet is associated with a decreased risk for GDM
  • Assaf-Balut et al. (PLoS One, 2017) report on their RCT that examined whether eating a Mediterranean diet with increased intake of EVOO and nuts decreases the risk for GDM

METHODS:

  • Prospective, randomized controlled trial (RCT)
  • Inclusion: Normoglycemic pregnant women were invited to join the study at 12-14 weeks at first ultrasound
  • Both Intervention and Control Group received basic MedDiet
    • ≥ 2 servings/day of vegetables, ≥ 3 servings/day of fruit, 3 servings/day of skimmed dairy products, wholegrain cereals, 2-3 servings of legumes/week, moderate to high consumption of fish
    • Low consumption of red and processed meat
    • Avoidance of refined grains, processed baked goods, pre-sliced bread, soft drinks and fresh juices, fast foods and precooked meals
    • All participants were encouraged to walk ≥ 30 minutes/day
  • Women were randomized to
    • Intervention Group: MedDiet plus ≥ 40 mL EVOO and handful of pistachios (20-30g)
    • Control Group: Standard diet with limited fat intake, including EVOO and nuts
  • Primary outcome
    • GDM incidence at 24-28 weeks
  • Secondary outcomes
    • Gestational weight gain (GWG), pregnancy-induced hypertension, caesarean section (CS), preterm delivery, perineal trauma, small and large for gestational age (SGA and LGA) and admissions to neonatal intensive care unit
  • Analysis was by intention-to-treat

RESULTS:

  • Data was collected from 874 women (440 controls/434 intervention arm)
  • 23.4% of the control group and 17.1% of the intervention group (IG) were diagnosed with GDM
  • Comparing the intervention to the control group
    • Crude relative risk (RR) for GDM was 0.73 (95% CI 0.56-0.95; p = 0.020)
    • adjusted multivariable analysis, RR 0.75 (95% CI 0.57-0.98; p = 0.039)
  • Intervention group also had reduced rates of insulin-treated GDM, prematurity, GWG at 24-28 and 36-38 weeks, emergency CS, perineal trauma, and SGA and LGA newborns (all p<0.05)

CONCLUSION:

  • A MedDiet diet supplemented with EVOO and pistachio nuts reduces the incidence of GDM and improves several maternal and neonatal outcomes

Learn More – Primary Sources:

A Mediterranean diet with additional extra virgin olive oil and pistachios reduces the incidence of gestational diabetes mellitus (GDM): A randomized controlled trial: The St. Carlos GDM prevention study. 

 

image_pdfFavoriteLoadingFavorite

< Previous
All #Grand Rounds Posts
Next >

Related ObG Topics:

Practical obstetrics info for your women's healthcare practice
What Is The ‘One-Step’ GDM Screening Approach?
CONCEPTT Study: Time for Continuous Glucose Monitoring for All Pregnant Women with Type 1 Diabetes?
Practical obstetrics info for your women's healthcare practice
Gestational Diabetes Mellitus – Definitions, Risk Factors and Complications
Does the Mediterranean Diet Decrease Risk of Breast Cancer?
ACC/AHA Blood Pressure Guideline: New Classification System and Treatment Targets

Sections

  • COVID-19
  • Alerts
  • OB
  • GYN
    • GYN
    • Sexual Health
  • 2T US Atlas
  • The Genome
  • Primary Care
  • Your Practice
  • #Grand Rounds
  • My Bookshelf
  • Now@ObG
  • Media

ObG Library

  • Hysteroscopy
  • Fertility
  • Site Map/
  • © ObG Project/
  • Terms and Conditions/
  • Privacy/
  • Contact Us/
© ObG Project
SSL Certificate


  • Already an ObGFirst Member?
    Welcome back

    Log In

    Want to sign up?
    Get guideline notifications
    CME Included

    Sign Up

Get Guideline Alerts Direct to Your Phone
Try ObGFirst Free!

Sign In

Lost your password?

Sign Up for ObGFirst and Stay Ahead

  • - Professional guideline notifications
  • - Daily summary of a clinically relevant
    research paper
  • - Includes 1 hour of CME every month

ObGFirst Free Trial

Already a Member of ObGFirst®?

Please log in to ObGFirst to access the 2T US Atlas

Password Trouble?

Not an ObGFirst® Member Yet?

  • - Access 2T US Atlas
  • - Guideline notifications
  • - Daily research paper summaries
  • - And lots more!
ObGFirst Free Trial

Media - Internet

Computer System Requirements

OBG Project CME requires a modern web browser (Internet Explorer 10+, Mozilla Firefox, Apple Safari, Google Chrome, Microsoft Edge). Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, or Real Networks Real One Player.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information
presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Jointly provided by

NOT ENOUGH CME HOURS

It appears you don't have enough CME Hours to take this Post-Test. Feel free to buy additional CME hours or upgrade your current CME subscription plan

Subscribe

JOIN OBGFIRST AND GET CME/CE CREDITS

One of the benefits of an ObGFirst subscription is the ability to earn CME/CE credits from the ObG entries you read. Tap the button to learn more about ObGFirst

Learn More
Leaving ObG Website

You are now leaving the ObG website and on your way to PRIORITY at UCSF, an independent website. Therefore, we are not responsible for the content or availability of this site